Absci Corporation (NASDAQ:ABSI) is listed among the Best Get Rich Fast Stocks to Buy Right Now. Analysts have a consensus buy rating on the stock, with a median price target of $9, indicating an upside potential of 150.70%. H.C. Wainwright reaffirmed a ‘Buy’ rating, raising the price target to $8 on ABSI.

The company recently presented new preclinical data for its AI-designed antibody, ABS-201, showing potential to stimulate hair growth in human scalp tissue samples. ABS-201 targets the prolactin receptor to support stem cell preservation and prolong the active growth phase of hair follicles. IonQ (IONQ) saw an 11% jump in stock price.

Absci Corporation, based in Washington, is a generative AI drug-creation company founded in 2011. It integrates AI with scalable wet lab technologies to develop unique antibody therapeutics. While ABSI shows investment potential, there are other AI stocks with greater upside potential and less downside risk. Check out our report on the best short-term AI stock.

H.C. Wainwright’s confidence in ABS-201 program is driven by strong preclinical evidence showing potential to expand hair follicles in growth phase. ABS-201 may reduce hair shedding by targeting the resting phase. The company recently discussed the androgenetic alopecia program for ABS-201.

Read more at Yahoo Finance: Absci Corporation (ABSI) Draws Full Buy Consensus With 150% Upside Potential